From Name:
From Email:
To Name:
To Email:

Optional Message:


Adcetris approved to treat most common cutaneous lymphomas

from Pharmacy Practice News

The FDA granted approval to brentuximab vedotin, Adcetris Seattle Genetics, for the treatment of adults with primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides who have received prior systemic therapy. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063